On Cancer

and/or

111 Blog posts found

In the Clinic

Immunotherapy Combination Is Better than Chemotherapy for Non-Small Cell Lung Cancer

MSK’s Matthew Hellmann led an international, phase III trial looking at the combination of immunotherapy drugs ipilimumab and nivolumab.

MSK medical oncologist Matthew Hellmann

Finding

Immunotherapy Combination Offers a Better Chance at Longer Survival for Patients with Metastatic Kidney Cancer

Learn about how the immunotherapies ipilimumab (Yervoy®) and nivolumab (Opdivo®) could provide a new option for patients with metastatic renal cell carcinoma.

MSK medical oncologist Robert Motzer

In the Clinic

Immunotherapy Drug Shows Promise for Metastatic Merkel Cell Carcinoma

An immunotherapy drug might be an effective initial treatment for people with metastatic Merkel cell carcinoma.

Dermatologist examining skin on the face of older man.

Feature

The New Age of Colorectal Cancer: People under 50

Doctors are troubled by a puzzling spike in colorectal cancer among people in their 20s, 30s, and 40s. A new MSK effort aims to help them cope — and find out what’s going on.

MSK colorectal cancer patient Katie Rich with her familly

Q&A

The Latest on Genetic Testing for BRCA Mutations in Breast Cancer

An MSK medical oncologist and geneticist discusses the latest drug approved for breast cancer and how genetic testing can lead to new treatments.

Molecular model of olaparib

In the Clinic

After Isolated Limb Infusion, People with Melanoma Get a Second Chance at Life

Meet three people who were treated as part of a clinical trial for melanoma at Memorial Sloan Kettering.

In the Clinic

Chemotherapy-Immunotherapy Combination Aims to Knock Out Melanoma with a One-Two Punch

A new approach for treating melanoma combines the immunotherapy drug ipilimumab with chemotherapy that treats only the area affected by cancer.

Jedd Wolchok and Charlotte Ariyan in the lab

In the Clinic

Longest-Running CAR T Trial Shows Which Patients Benefit Most, Have Fewest Side Effects

For adults with chemotherapy-resistant leukemia, CAR T cell therapy can be a lifesaving treatment option. New results suggest how to make it safer.

Medical oncologist Jae Park

In the Clinic

An Unlikely Treatment for Triple-Negative Breast Cancer: Prostate Cancer Drugs

Doctors are developing treatment strategies that target the androgen receptor, which is found in many triple-negative breast cancers.

A yellow molecular model of the androgen receptor on brown background

Q&A

Immunotherapy Offers New Strategy for Treating Sarcoma

Some of the first clinical trials testing immunotherapy for the treatment of sarcoma are now under way at MSK. Here’s a snapshot of where the research stands.

Enlarged microscopic image of blue-green immune cells surrounding one blue cancer cell.